| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/24/2013 | CN102370866B Medicinal composition for preventing and treating diabetic nerve pathology |
| 07/24/2013 | CN102357195B Medicinal composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof |
| 07/24/2013 | CN102327368B Chinese lizardtail rhizome or herb rootstock total effective fraction and preparation method and application thereof |
| 07/24/2013 | CN102228457B Pharmaceutical composition for treating diabetes and complication thereof |
| 07/24/2013 | CN102219759B Aryl methanamide compounds and preparation method, medicinal compositions and application thereof |
| 07/24/2013 | CN102188370B Resveratrol injection solution and intravenous injection |
| 07/24/2013 | CN102058560B Dihydromyricetin soft capsules and preparation method thereof |
| 07/24/2013 | CN102020546B PTP1B inhibitor and preparation and application in preparing drug for treating type 2 diabetes mellitus thereof |
| 07/24/2013 | CN101668760B Aminopyrimidines useful as inhibitors of protein kinases |
| 07/24/2013 | CN101652147B Combined use of dipeptidyl peptidase IV inhibitor compound and sweetener |
| 07/24/2013 | CN101378666B Carbohydrate composition for flat glucose response |
| 07/24/2013 | CN101362773B Heterocyclic boronic acid compounds |
| 07/24/2013 | CN101258131B 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 07/24/2013 | CN101129476B Application of mulberry twigs alkaloid valid target in preparing antidiabetics medicament |
| 07/23/2013 | US8492560 Quinazoline derivatives as angiogenesis inhibitors |
| 07/23/2013 | US8492517 Melanocortin-1 receptor-specific cyclic peptides |
| 07/23/2013 | US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/23/2013 | US8492363 Use of difructose anhydride-containing composition |
| 07/23/2013 | US8492330 Formulation comprising GLP-1 |
| 07/23/2013 | CA2664004C Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 07/23/2013 | CA2544574C Stable vitamin b6 derivative |
| 07/23/2013 | CA2438886C Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture |
| 07/23/2013 | CA2357950C Therapeutic phosphodiesterase inhibitors |
| 07/18/2013 | WO2013106702A1 Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions |
| 07/18/2013 | WO2013106647A1 Supercritical guggul extracts and uses thereof |
| 07/18/2013 | WO2013106547A1 Beta-cell replication promoting compounds and methods of their use |
| 07/18/2013 | WO2013106358A1 Method of treating hyperlipidemia and atherosclerosis with mir-30c |
| 07/18/2013 | WO2013106349A1 Use of the aminoalkylindole jwh-073-m4 and related compounds as neutral cb1 recptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases |
| 07/18/2013 | WO2013105753A1 Substituted piperidine derivatives and methods for preparing the same |
| 07/18/2013 | WO2013105676A1 Benzimidazole derivatives as mch receptor antagonists |
| 07/18/2013 | WO2013105617A1 Use of disrupted product of chlorella cell wall for reducing serum resistin level |
| 07/18/2013 | WO2013105048A2 New use of zerumbone and compositions comprising zerumbone |
| 07/18/2013 | WO2013104929A1 Peptides and peptide derivatives based on xenin |
| 07/18/2013 | WO2013104613A1 Macrocyclic amides as protease inhibitors |
| 07/18/2013 | WO2013104575A1 Thienopyrimidine compounds |
| 07/18/2013 | WO2013104257A1 Polycyclic derivatives, preparation method and medical uses thereof |
| 07/18/2013 | WO2013070852A3 Compounds and compositions used to epigenetically transform cells and methods related thereto |
| 07/18/2013 | WO2013016278A3 Modulators of antiviral signaling pathways and therapeutic uses thereof |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130184325 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 07/18/2013 | US20130184281 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 07/18/2013 | US20130184242 Pharmaceutical Composition for Topical Application |
| 07/18/2013 | US20130181107 Furnace mount and method of installation |
| 07/18/2013 | CA2860968A1 Use of cell wall disrupted product of chlorella for reducing serum resistin level |
| 07/18/2013 | CA2860842A1 Methods of treating or preventing insulin resistance and associated diseases and conditions |
| 07/18/2013 | CA2852173A1 Macrocyclic amides as protease inhibitors |
| 07/17/2013 | EP2615114A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 07/17/2013 | EP2615113A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 07/17/2013 | EP2615109A1 Localized pegylated modifications of exendin-4 analogs and use thereof |
| 07/17/2013 | EP2615094A2 Sesterterpene compounds and use thereof |
| 07/17/2013 | EP2614822A2 Atorvastatin Derivatives |
| 07/17/2013 | EP2614085A2 Anti-il-1 beta antibodies and methods of use |
| 07/17/2013 | EP2614054A1 Ethyne derivatives, pharmaceutical compositions and uses thereof |
| 07/17/2013 | EP2613798A1 Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients |
| 07/17/2013 | EP2613786A2 Treatment of diseases |
| 07/17/2013 | EP2613767A2 Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin |
| 07/17/2013 | EP2613766A2 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin |
| 07/17/2013 | CN103209981A Hetero ring-fused imidazole derivative having ampk activating effect |
| 07/17/2013 | CN103209957A Process for preparing aminoadamantyl carbamate derivatives |
| 07/17/2013 | CN103209711A Double-acylated GLP-1 derivatives |
| 07/17/2013 | CN103205337A Glutinous rice wine prepared with sunflower discs and gynostemma pentaphyllum and preparation method thereof |
| 07/17/2013 | CN103204944A Long-acting immune fusion protein for treating diabetes mellitus |
| 07/17/2013 | CN103204921A Secretory protein with chemotactic activity, and coding sequence and application thereof |
| 07/17/2013 | CN103204894A Novel corosolic acid derivative, preparation method thereof and application thereof in preparing diabetes medicaments |
| 07/17/2013 | CN103204850A Acetylsalicylic acid berberine salt, preparation method and application thereof |
| 07/17/2013 | CN103204839A Synchronous preparation method of effective ingredient of licorice |
| 07/17/2013 | CN103204827A Benzothiadiazole compounds as protein kinase inhibitors, and preparation method and application thereof |
| 07/17/2013 | CN103204825A Benzothiazole compounds as protein kinase inhibitors, and preparation method and application thereof |
| 07/17/2013 | CN103204822A Benzoxazole compounds as protein kinase inhibitors, and preparation method and application thereof |
| 07/17/2013 | CN103204813A Condensed imidazole derivatives as TRPV3 antagonist |
| 07/17/2013 | CN103203023A Pdgf Amphiphilic Polymer Complex |
| 07/17/2013 | CN103203019A Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders |
| 07/17/2013 | CN103202955A Dendrobium nobile oral liquid capable of reducing blood lipids |
| 07/17/2013 | CN103202926A Soft capsule used for preventing and treating cardiovascular and cerebrovascular diseases and delaying senescence |
| 07/17/2013 | CN103202882A Weight losing method for quickly decomposing fat and navel patch |
| 07/17/2013 | CN103202865A Micronized Chinese yew particles, compound for health bath obtained by using Chinese yew micronized particle and preparation method thereof |
| 07/17/2013 | CN103202858A Pig bone nutrient and bone-strengthening and blood-generating oral liquid prepared by same |
| 07/17/2013 | CN103202849A New use of polyene phosphatidyl choline medicine in treatment of obesity and insulin resistance syndromes (metabolic syndromes) |
| 07/17/2013 | CN103202844A Compound vitamin (3) pharmaceutical composition for injection and preparation method thereof |
| 07/17/2013 | CN103202840A Salts Of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 07/17/2013 | CN103202830A Compound potassium citrate and sodium citrate granule and preparation method thereof |
| 07/17/2013 | CN103202829A Application of rhein or rhein compound-arginine complex in preparation of medicines for treating diabetic vascular complications |
| 07/17/2013 | CN103202824A Application of pinitol to pharmacy and health care product |
| 07/17/2013 | CN103202423A Fructus trichosanthis polysaccharide composite capsule and preparation method thereof |
| 07/17/2013 | CN103202353A Lipid mixture for infant nutrition |
| 07/17/2013 | CN102657626B Medicinal composite tablet of pioglitazone medicine |
| 07/17/2013 | CN102626510B Traditional Chinese medicine composite for treating diabetic cardiopathy and preparation method and applications thereof |
| 07/17/2013 | CN102599595B Health beverage with blood fat reducing function, traditional Chinese medicine and preparation method |
| 07/17/2013 | CN102558340B Glucagon-like peptide (GLP)-1 derivative |
| 07/17/2013 | CN102558339B GLP-1(Glucagon-like Peptide 1) derivative |
| 07/17/2013 | CN102552682B Medicine for treating diabetes |
| 07/17/2013 | CN102526248B Traditional Chinese medicine prescription capable of curing diabetes wound fester and continuously reducing blood sugar |
| 07/17/2013 | CN102462787B Chinese medicine composition for treating hypertension and improving hyperlipidemia and preparation method of Chinese medicine composition |
| 07/17/2013 | CN102441118B Application of medicinal composition in preparing medicaments for treating diabetes mellitus and impaired glucose tolerance |
| 07/17/2013 | CN102429865B Preparation method of super-micro molecular iron dextran |
| 07/17/2013 | CN102406832B Chlorogenic acid ecological agent derived from arctium lappa L |
| 07/17/2013 | CN102389454B Compound gynura divaricata antidiabetic preparation and preparation method thereof |
| 07/17/2013 | CN102379887B Cardiovascular disease treating medicament and preparation method and application thereof |
| 07/17/2013 | CN102274267B Preparation method of vacuum packaged pseudostellaria roots |
| 07/17/2013 | CN102241644B Alpha-azyl-3-aryl propionamido thiazole derivative, preparation method and purpose thereof |